Investor mix
6 investors on record; lead investors include Inveready.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 33% |
| Accelerator & incubator | 2 | 33% |
| Other / undisclosed | 2 | 33% |
Developer of drugs targeting leukemic stem cells
6 investors on record; lead investors include Inveready.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 33% |
| Accelerator & incubator | 2 | 33% |
| Other / undisclosed | 2 | 33% |